One of the world's largest leaf tobacco suppliers, Universal Corporation buys, processes, and sells flue-cured, burley, and other tobaccos to consumer brands, and also makes specialty plant-based ingredients like juices, concentrates, and botanical extracts for food and beverage companies. It was born in 1918 in Richmond, Virginia, when Jacquelin P. Taylor merged six independent leaf merchants into the Universal Leaf Tobacco Company, with the name chosen to signal its global ambitions. Today it also counts many seasonal workers among its more than 25,000 employees, reflecting the farming rhythms of its harvest.
Tobacco operating income fell 90% as product mix shifted and uncommitted inventory rose to 24% of the total.
Tobacco nearly vanished. fell 12% to $523.8 million and contracted 3.8 points to 15.3% as a less favorable product mix in Asia and lower sales reversed the prior year's gains. The company is sitting on $275 million in uncommitted tobacco — more than double a year ago — waiting for customers to commit.
Key takeaways
Tobacco Operations fell 90% to $3.5 million, driven by a less favorable product mix in Asia and lower sales, which more than offset the benefit of a 9% decline in shipment volumes.
Consolidated contracted 3.8 points to 15.3%, as cost of goods sold fell only 6% against a 12% decline, reflecting the shift toward lower-margin products.
Uncommitted tobacco inventories rose to $275.1 million, or 24% of total tobacco , up from $134.7 million (11%) a year ago, as customer purchase commitments were delayed amid what management described as global oversupply.
Section summaries
Management's Discussion and Analysis
Q1 FY2027 revenue fell 12% to $523.8M and operating income dropped 93% to $2.3M on lower tobacco volumes and unfavorable mix.
⌄
Consolidated decreased 12% to $523.8M, driven by a 9% drop in tobacco sales volumes and a 6% decline in tobacco sales prices.
Tobacco Operations plunged 90% to $3.5M due to less favorable product mix in Asia and lower carryover crop sales.
Ingredients Operations slipped 3% to $86.7 million, and the swung to a $0.7 million operating loss, pressured by product mix, high fixed costs, and $1.4 million in write-downs.
Net cash used in operations improved by $88.0 million to $117.1 million, reflecting lower needs from slower green tobacco purchases and lower prices.
decreased $51.6 million to $1.0 billion, with the ratio flat at 42%, supported by $174 million in cash and $635 million available under a committed .
What changed
The 19.1% reported in Q1 FY2026 — flagged then as potentially unsustainable once the favorable Asian product mix normalized — did not hold. Gross margin fell to 15.3%, the lowest quarterly level in the table, as that mix reversed.
The Ingredients 's 42% drop in in Q1 FY2026 was flagged as a possible one-quarter event. It was not: the segment swung to a $0.7 million operating loss this quarter, its third consecutive quarter without a meaningful profit.
Uncommitted tobacco , which stood at 11% of total inventory a year ago and was flagged as low, has more than doubled to 24%, signaling that the tight leaf supply that supported pricing in prior periods has given way to global oversupply.
The $52.0 million in write-downs recorded in FY2026 was flagged as a potential one-year event. This quarter's filing reports $1.4 million in Ingredients inventory write-downs but does not disclose a large tobacco , suggesting the heavy charges may have been concentrated in the prior year.
What to watch
Whether the $275.1 million in uncommitted tobacco (24% of the total) finds buyers in the next two quarters, or whether it leads to further inventory write-downs that pressure .
The trajectory of , now at 15.3% — the lowest quarterly level in the table — and whether it can recover as the fiscal year progresses or remains depressed by the less favorable product mix.
Whether the Ingredients can return to profitability after three consecutive quarters of operating losses, or whether the higher fixed costs and product mix headwinds persist into the second half of fiscal 2027.
The pace at which the $117.1 million seasonal cash outflow reverses, and whether turns positive at a level sufficient to reduce the $1.0 billion position.
Ingredients Operations slipped 3% to $86.7M, and the swung to a $0.7M operating loss on product mix, high fixed costs, and $1.4M in .
Net cash used in operations was $117.1M, an $88.0M improvement , reflecting lower needs from slower green tobacco purchases and lower prices.
rose to $275.1M (24% of total) from $134.7M (11%) a year ago due to delayed customer purchase commitments amid global oversupply.
decreased $51.6M to $1.0B, and the net debt-to-net capitalization ratio remained flat at 42%, supported by $174M in cash and $635M available under a committed .
Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes to the Company's market risk during the three months ended June 30, 2026. For a discussion of the Company's exposure to market risk, refer to the Company's market risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Di…
⌄
There have been no material changes to the Company's market risk during the three months ended June 30, 2026. For a discussion of the Company's exposure to market risk, refer to the Company's market risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" of the 2026 Form 10-K.
Other Legal Matters Some of our subsidiaries are involved in litigation or legal matters incidental to their business activities. While the outcome of these matters cannot be predicted with certainty, we are vigorously defending them and do not currently expect that any of them…
⌄
Other Legal Matters
Some of our subsidiaries are involved in litigation or legal matters incidental to their business activities. While the outcome of these matters cannot be predicted with certainty, we are vigorously defending them and do not currently expect that any of them will have a material adverse effect on our business or financial position. However, should one or more of these matters be resolved in a manner adverse to our current expectation, the effect on our results of operations for a particular fiscal reporting period could be material.
There are no material changes to the risk factors previously disclosed in our 2026 Form 10-K. In evaluating our risks, readers should carefully consider the risk factors discussed in our 2026 Form 10-K, which could materially affect our business, financial condition or operating…
⌄
There are no material changes to the risk factors previously disclosed in our 2026 Form 10-K. In evaluating our risks, readers should carefully consider the risk factors discussed in our 2026 Form 10-K, which could materially affect our business, financial condition or operating results, in addition to the other information set forth in this Form 10-Q and in our other filings with the SEC.